Eradivir

Developer of immunotherapies for the treatment of infectious diseases

placeWest Lafayette, Indiana, United States calendar_todayFounded 2020 groups6 employees language eradivir.com

Social engagement

Social engagement: 1.6K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Research Bridge Partners.

Investor typeCountShare
Venture capital125%
Other / undisclosed375%

Recent activity

30 Apr 2026
Event
ICAR 2026
16 Apr 2026
Event
ESCMID Global 2026
5 Mar 2026
Leadership hire
Co-Founder and Chief Scientific Officer
Coming soon